OGIVRI™ LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL
Product details
Registration number: SIN15850P
Classification: Prescription Only
Active ingredients: (Powder) Trastuzumab
Strength: 440 mg/vial
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Registrant: CEDAR PHARMACEUTICALS PTE. LTD.
ATC code: L01XC03
HSA approval date: 4 November 2019
Manufacturer(s): Biocon Biologics Limited (Powder and Diluent)
Manufacturing country/countries: INDIA
What are the HSA registration number and classification for OGIVRI™ LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15850P
Classification: Prescription Only
What active ingredients and strength are recorded for OGIVRI™ LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: (Powder) Trastuzumab
Strength: 440 mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for OGIVRI™ LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for OGIVRI™ LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL?
According to the HSA dataset updated 7 August 2026:
Registrant: CEDAR PHARMACEUTICALS PTE. LTD.
Which manufacturers and countries are listed for OGIVRI™ LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Biocon Biologics Limited (Powder and Diluent)
Manufacturing country/countries: INDIA
Where can I look up OGIVRI™ LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15850P or the exact product name OGIVRI™ LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL. The general register link does not preselect this product.
What are the source dates for this OGIVRI™ LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this OGIVRI™ LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15850P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)